These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
250 related articles for article (PubMed ID: 9396699)
1. Mechanisms of action of anti-GM1 and anti-GQ1b ganglioside antibodies in Guillain-Barré syndrome. Willison HJ; O'Hanlon G; Paterson G; O'Leary CP; Veitch J; Wilson G; Roberts M; Tang T; Vincent A J Infect Dis; 1997 Dec; 176 Suppl 2():S144-9. PubMed ID: 9396699 [TBL] [Abstract][Full Text] [Related]
2. [Clinical utility of measurement for anti-GM1 and anti-GQ1b antibodies]. Tagawa Y; Matsumoto Y; Yuki N No To Shinkei; 1998 Sep; 50(9):849-53. PubMed ID: 9789308 [TBL] [Abstract][Full Text] [Related]
3. Electrodiagnostic findings related to anti-GM1 and anti-GQ1b antibodies in Guillain-Barré syndrome. Jacobs BC; Meulstee J; van Doorn PA; van der Meché FG Muscle Nerve; 1997 Apr; 20(4):446-52. PubMed ID: 9121502 [TBL] [Abstract][Full Text] [Related]
4. Mapping immunoreactive epitopes in the human peripheral nervous system using human monoclonal anti-GM1 ganglioside antibodies. O'Hanlon GM; Paterson GJ; Veitch J; Wilson G; Willison HJ Acta Neuropathol; 1998 Jun; 95(6):605-16. PubMed ID: 9650753 [TBL] [Abstract][Full Text] [Related]
5. Antibodies to gangliosides in Guillain-Barré syndrome: specificity and relationship to clinical features. Gregson NA; Koblar S; Hughes RA Q J Med; 1993 Feb; 86(2):111-7. PubMed ID: 8464986 [TBL] [Abstract][Full Text] [Related]
6. Autoantibodies to peripheral nerve glycosphingolipids SPG, SLPG, and SGPG in Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy. Yuki N; Tagawa Y; Handa S J Neuroimmunol; 1996 Oct; 70(1):1-6. PubMed ID: 8862128 [TBL] [Abstract][Full Text] [Related]
7. Antibodies to ganglioside complexes consisting of asialo-GM1 and GQ1b or GT1a in Fisher and Guillain-Barré syndromes. Ogawa G; Kaida K; Kusunoki S; Ueda M; Kimura F; Kamakura K J Neuroimmunol; 2009 Sep; 214(1-2):125-7. PubMed ID: 19631994 [TBL] [Abstract][Full Text] [Related]
8. Molecular mimicry between gangliosides and lipopolysaccharides of Campylobacter jejuni isolated from patients with Guillain-Barré syndrome and Miller Fisher syndrome. Yuki N J Infect Dis; 1997 Dec; 176 Suppl 2():S150-3. PubMed ID: 9396700 [TBL] [Abstract][Full Text] [Related]
9. Anti-ganglioside antibodies can bind peripheral nerve nodes of Ranvier and activate the complement cascade without inducing acute conduction block in vitro. Paparounas K; O'Hanlon GM; O'Leary CP; Rowan EG; Willison HJ Brain; 1999 May; 122 ( Pt 5)():807-16. PubMed ID: 10355667 [TBL] [Abstract][Full Text] [Related]
10. Campylobacter gene polymorphism as a determinant of clinical features of Guillain-Barré syndrome. Koga M; Takahashi M; Masuda M; Hirata K; Yuki N Neurology; 2005 Nov; 65(9):1376-81. PubMed ID: 16162859 [TBL] [Abstract][Full Text] [Related]
11. The immunobiology of Guillain-Barré syndromes. Willison HJ J Peripher Nerv Syst; 2005 Jun; 10(2):94-112. PubMed ID: 15958123 [TBL] [Abstract][Full Text] [Related]
12. Patterns and serial changes in electrodiagnostic abnormalities of axonal Guillain-Barré syndrome. Hiraga A; Kuwabara S; Ogawara K; Misawa S; Kanesaka T; Koga M; Yuki N; Hattori T; Mori M Neurology; 2005 Mar; 64(5):856-60. PubMed ID: 15753422 [TBL] [Abstract][Full Text] [Related]
13. Axonal degeneration in the Guillain-Barré syndrome and anti-GM1 ganglioside antibodies. Yuki N; Sato S; Inuzuka T; Miyatake T; Yoshino H Muscle Nerve; 1992 Jan; 15(1):116. PubMed ID: 1732757 [No Abstract] [Full Text] [Related]
14. [Guillain-Barre syndrome and antibodies to ganglioside GM1. Case report]. Trisković I; Dimitrijević Lj; Rakocević-Stojanović V; Trikić R; Apostolski S Srp Arh Celok Lek; 1996; 124(7-8):210-3. PubMed ID: 9102850 [TBL] [Abstract][Full Text] [Related]
15. An anti-ganglioside antibody-secreting hybridoma induces neuropathy in mice. Sheikh KA; Zhang G; Gong Y; Schnaar RL; Griffin JW Ann Neurol; 2004 Aug; 56(2):228-39. PubMed ID: 15293275 [TBL] [Abstract][Full Text] [Related]
16. [Antiganglioside antibodies: when, which and for what]. Gallardo E; Rojas-García R; Belvís R; Serrano-Munuera C; Ortiz E; Ortiz N; Grau J; Illa I Neurologia; 2001; 16(7):293-7. PubMed ID: 11485721 [TBL] [Abstract][Full Text] [Related]
17. Carbohydrate mimicry between human ganglioside GM1 and Campylobacter jejuni lipooligosaccharide causes Guillain-Barre syndrome. Yuki N; Susuki K; Koga M; Nishimoto Y; Odaka M; Hirata K; Taguchi K; Miyatake T; Furukawa K; Kobata T; Yamada M Proc Natl Acad Sci U S A; 2004 Aug; 101(31):11404-9. PubMed ID: 15277677 [TBL] [Abstract][Full Text] [Related]
18. Anti-GM1 antibodies in patients with Guillain-Barré syndrome. van den Berg LH; Marrink J; de Jager AE; de Jong HJ; van Imhoff GW; Latov N; Sadiq SA J Neurol Neurosurg Psychiatry; 1992 Jan; 55(1):8-11. PubMed ID: 1548508 [TBL] [Abstract][Full Text] [Related]
19. Animal model of axonal Guillain-Barré syndrome induced by sensitization with GM1 ganglioside. Yuki N; Yamada M; Koga M; Odaka M; Susuki K; Tagawa Y; Ueda S; Kasama T; Ohnishi A; Hayashi S; Takahashi H; Kamijo M; Hirata K Ann Neurol; 2001 Jun; 49(6):712-20. PubMed ID: 11409422 [TBL] [Abstract][Full Text] [Related]